NVIDIA Discloses $63.4B Portfolio: $30B Intel Stake, $21B SpaceX, $4.7B CoreWeave
NVDA sits 37% above its 52-week low of $164.07.
Summary
NVIDIA's 13F filing discloses a $63.4 billion portfolio, including a $30 billion stake in Intel and a $21 billion stake in SpaceX, as of June 30, 2026.
Key Events · Ownership and Investor Activity · NVDA
-
Intel Stake Tops Portfolio
NVIDIA holds 214.8 million shares of Intel valued at $30.0 billion, making it the largest disclosed position and a notable bet on a direct competitor.
-
SpaceX Position Valued at $21B
NVIDIA owns 122.8 million shares of SpaceX worth $21.0 billion, a significant private-company investment.
-
CoreWeave Stake at $4.7B
NVIDIA holds 47.2 million shares of CoreWeave valued at $4.7 billion, reinforcing its AI cloud partnerships.
-
Other Holdings
Portfolio also includes Coherent ($3.1B), Nokia ($2.2B), Synopsys ($2.2B), Nebius Group ($328.8M), and Generate Biomedicines ($14.1M).
Analysis · NVDA · Manufacturing
NVIDIA's 13F reveals a $63.4 billion investment portfolio as of June 30, 2026, dominated by a $30.0 billion position in Intel (214.8 million shares) and a $21.0 billion stake in SpaceX (122.8 million shares). The Intel stake is particularly notable given NVIDIA's dominance in AI chips and Intel's struggles — it suggests a strategic or financial bet on a competitor. The SpaceX position, while large, is a private holding that may reflect NVIDIA's interest in space-based compute or simply a high-conviction investment. The CoreWeave stake ($4.7 billion) aligns with NVIDIA's AI cloud partnerships, while smaller positions in Coherent, Nokia, Synopsys, Nebius, and Generate Biomedicines round out a diversified tech portfolio. This is the first public disclosure of these holdings, making it a fresh data point for investors assessing NVIDIA's capital allocation beyond its core business.
At the time of this filing, NVDA was trading at $224.95 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.4T. The 52-week trading range was $164.07 to $236.54. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.